Please ensure Javascript is enabled for purposes of website accessibility

Why Perrigo Stock Fell 38% in December

By Demitri Kalogeropoulos - Updated Apr 15, 2019 at 10:24PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Prospects of a huge tax bill spooked investors last month.

What happened

Pharmaceutical specialist Perrigo (PRGO 2.23%) trailed the market by a wide margin last month as the stock lost 38% compared to a 9% slump in the S&P 500, according to data provided by S&P Global Market Intelligence.

Two scientists performing clinical research.

Image source: Getty Images.

So what

December's swoon came as investors reacted to some shocking tax news. Perrigo revealed late in the month that the Irish Tax Appeals Commission has sent it a tax bill of roughly $1.9 billion, plus interest and penalties, or about one quarter of the company's market capitalization before the stock decline. Irish tax authorities found that Perrigo didn't pay the appropriate taxes related to its sale of the rights to its multiple sclerosis drug Tysabri.

Now what

Perrigo disagrees with the Irish authorities' assessment and says that the company will ultimately prevail in contesting the charge. Any payments won't be due until a final ruling, too, which won't be for years. However, a $2 billion potential charge is a significant risk clouding investors' view of Perrigo's finances right now. Thus, until more clarity develops on the issue that supports management's claims that the charge won't be applied, the stock isn't likely to recover from its December hit.

Check out the latest Perrigo earnings call transcript.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Perrigo Company plc Stock Quote
Perrigo Company plc
$41.21 (2.23%) $0.90

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/25/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.